
CAS 1210608-43-7
:N-(4-((1R,3S,5S)-3-amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide
Description:
N-(4-((1R,3S,5S)-3-amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide is a complex organic compound characterized by its unique structural features, including a pyridine ring and a picolinamide moiety. This substance exhibits a chiral center, contributing to its stereochemistry, which can influence its biological activity and interactions. The presence of fluorine atoms in the difluorophenyl group enhances its lipophilicity and may improve its binding affinity to biological targets. The compound's amine group is likely to participate in hydrogen bonding, which can be crucial for its solubility and reactivity. Additionally, the cyclohexyl group provides a hydrophobic character, potentially affecting the compound's pharmacokinetics. Overall, this compound may be of interest in medicinal chemistry, particularly in the development of pharmaceuticals targeting specific biological pathways, owing to its intricate structure and potential for selective activity. Further studies would be necessary to elucidate its specific properties and applications in various fields.
Formula:C24H23F3N4O
Synonyms:- 2-Pyridinecarboxamide, N-[4-[(1R,3S,5S)-3-amino-5-methylcyclohexyl]-3-pyridinyl]-6-(2,6-difluorophenyl)-5-fluoro-
- PIM447 (LGH447)
- N-(4-((1R,3S,5S)-3-amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide
- EOS-60671
- PIM447 (LGH447) Free Base
- PIM447
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
PIM 447
CAS:PIM 447 is a tyrosine kinase inhibitor that inhibits the activity of JAK2. This drug has been shown to inhibit the growth of prostate cancer cells in tissue culture and may be useful for the treatment of t-cell lymphomas. PIM 447 binds to a region on the JAK2 protein that is required for its function and prevents it from phosphorylating tyrosine residues. It also inhibits the transcriptional activity of JAK2, which may lead to inhibition of cell proliferation and anti-tumour effects. Monoclonal antibodies against PIM 447 have been developed for use as a therapy for B-cell malignancies.Formula:C24H23F3N4OPurity:Min. 95%Molecular weight:440.46 g/molPIM447
CAS:PIM447 (LGH447) is a pan-PIM kinase inhibitor with anti-tumor and bone protective effects. PIM447 reduces the viability, and motility of HuH6 cell.Formula:C24H23F3N4OPurity:98.97%Color and Shape:SolidMolecular weight:440.46




